chr19-41755684-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002483.7(CEACAM6):āc.46A>Gā(p.Lys16Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000033 in 1,605,400 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002483.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CEACAM6 | NM_002483.7 | c.46A>G | p.Lys16Glu | missense_variant | 1/6 | ENST00000199764.7 | |
CEACAM6 | XM_011526990.3 | c.46A>G | p.Lys16Glu | missense_variant | 1/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CEACAM6 | ENST00000199764.7 | c.46A>G | p.Lys16Glu | missense_variant | 1/6 | 1 | NM_002483.7 | P1 | |
CEACAM6 | ENST00000595740.1 | c.46A>G | p.Lys16Glu | missense_variant | 3/4 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152136Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000748 AC: 18AN: 240530Hom.: 0 AF XY: 0.0000613 AC XY: 8AN XY: 130592
GnomAD4 exome AF: 0.0000337 AC: 49AN: 1453264Hom.: 0 Cov.: 30 AF XY: 0.0000332 AC XY: 24AN XY: 723188
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152136Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 29, 2022 | The c.46A>G (p.K16E) alteration is located in exon 1 (coding exon 1) of the CEACAM6 gene. This alteration results from a A to G substitution at nucleotide position 46, causing the lysine (K) at amino acid position 16 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at